An early GLP-1 drug, Exendin-4, was found to reduce conditioned place preference and dopamine release in the nucleus accumbens in response to nicotine, cocaine, and amphetamine (a brain region that is understood to play a crucial role in the bodys reward system) as well as to reduce cocaine self-administration and seeking behavior in rats
In recent years, GLP-1 role in neuronal pathways has expanded its therapeutic potential
P.HarituniansT.JacobsJ
Pre-Treatment Readiness: Who Benefits and Important Safety Considerations Semaglutide is appropriate for adults with weight-related conditions or type 2 diabetes under medical supervision
Anaphylactic reactions, asthma, bronchial hyperreactivity, bronchospasm, oropharyngeal swelling, facial swelling, angioedema, pharyngeal edema, type IV hypersensitivity reactions have been reported in patients treated with liraglutide in clinical trials